NASDAQ:MRGE - Merge Healthcare Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.0418 0.00 (0.00 %)
(As of 02/17/2019 09:23 AM ET)
Previous Close$0.0418
Today's Range$0.0380 - $0.0450
52-Week Range$0.0066 - $0.1375
Volume2.60 million shs
Average Volume534,469 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Merge Healthcare Incorporated develops software solutions that facilitate the sharing of images. The Company operates through two segments: Merge Healthcare and Merge DNA. The Company's Merge Healthcare segment markets, sells and implements interoperability, imaging and clinical solutions to healthcare providers. The Company's Merge DNA (Data and Analytics) segment focuses on the marketing and sale of data capture software for clinical trials and related solutions. The Merge Healthcare segment offers licensing of software (including upgrades), the sale of hardware, professional services, maintenance and electronic data interchange (EDI) services. The Merge DNA segment offers on-premise licensing and hosting arrangements, and professional services.

Receive MRGE News and Ratings via Email

Sign-up to receive the latest news and ratings for MRGE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Technology
SectorN/A
Current SymbolNASDAQ:MRGE
CUSIP58949910
Phone+1-262-3670700

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
OptionableNot Optionable

Merge Healthcare (NASDAQ:MRGE) Frequently Asked Questions

What is Merge Healthcare's stock symbol?

Merge Healthcare trades on the NASDAQ under the ticker symbol "MRGE."

How were Merge Healthcare's earnings last quarter?

Merge Healthcare Inc. (NASDAQ:MRGE) announced its quarterly earnings data on Wednesday, October, 29th. The technology company reported $0.05 EPS for the quarter, beating the Zacks' consensus estimate of $0.03 by $0.02. The technology company earned $54 million during the quarter, compared to analysts' expectations of $53.60 million. The company's revenue for the quarter was down 5.6% on a year-over-year basis. During the same period in the prior year, the company posted $0.02 earnings per share. View Merge Healthcare's Earnings History.

Has Merge Healthcare been receiving favorable news coverage?

Media coverage about MRGE stock has been trending positive this week, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Merge Healthcare earned a news sentiment score of 2.4 on InfoTrie's scale. They also gave news stories about the technology company a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the company's share price in the next several days.

How do I buy shares of Merge Healthcare?

Shares of MRGE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Merge Healthcare's stock price today?

One share of MRGE stock can currently be purchased for approximately $0.0418.

What is Merge Healthcare's official website?

The official website for Merge Healthcare is http://www.merge.com/.

How can I contact Merge Healthcare?

Merge Healthcare's mailing address is 71 S Wacker Dr Fl 20, CHICAGO, IL 60606-4637, United States. The technology company can be reached via phone at +1-262-3670700.


MarketBeat Community Rating for Merge Healthcare (NASDAQ MRGE)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  133 (Vote Outperform)
Underperform Votes:  139 (Vote Underperform)
Total Votes:  272
MarketBeat's community ratings are surveys of what our community members think about Merge Healthcare and other stocks. Vote "Outperform" if you believe MRGE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MRGE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel